{"entity":{"type":"insider","cik":"0001391045","url":"/insider/0001391045","json_url":"/insider/0001391045.json","name":"Legault Pierre","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":9,"first":"2021-03-16","last":"2023-01-13","span_basis":"filed_date"},"name_variants":[{"name":"Legault Pierre","source":"filing","n_filings":9,"first_seen":"2021-03-16","last_seen":"2023-01-13"}],"transactions":[{"id":8170181,"accession":"0001562180-23-000413","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-23-000413","line_url":"/filing/0001562180-23-000413","is_derivative":false,"issuer_cik":"0001391045","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001391045","owner_cik":"0001391045","owner_name":"Legault Pierre","owner_display_name":"Legault Pierre","owner_url":"/insider/0001391045","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":405000.0,"total_display":"405,000.00","total_whole":"405,000","shares_owned_after":32000.0,"shares_owned_after_display":"32,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-13","filed_date":"2023-01-13","scope":"insider","n_lines":2},{"id":8170169,"accession":"0001562180-23-000413","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-23-000413","line_url":"/filing/0001562180-23-000413#line-2","is_derivative":false,"issuer_cik":"0001391045","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001391045","owner_cik":"0001391045","owner_name":"Legault Pierre","owner_display_name":"Legault Pierre","owner_url":"/insider/0001391045","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":26.7409,"price_display":"26.74","price_state":"stated","total_value":641781.6,"total_display":"641,781.60","total_whole":"641,782","shares_owned_after":32000.0,"shares_owned_after_display":"32,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-12","filed_date":"2023-01-13","scope":"insider"},{"id":6782892,"accession":"0001562180-22-005979","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-22-005979","line_url":"/filing/0001562180-22-005979","is_derivative":false,"issuer_cik":"0001391045","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001391045","owner_cik":"0001391045","owner_name":"Legault Pierre","owner_display_name":"Legault Pierre","owner_url":"/insider/0001391045","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":23.0159,"price_display":"23.02","price_state":"stated","total_value":552381.6,"total_display":"552,381.60","total_whole":"552,382","shares_owned_after":32000.0,"shares_owned_after_display":"32,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-05","filed_date":"2022-08-09","scope":"insider","n_lines":2},{"id":5407251,"accession":"0001209191-21-071007","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-071007","line_url":"/filing/0001209191-21-071007#line-6","is_derivative":false,"issuer_cik":"0001391045","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001391045","owner_cik":"0001391045","owner_name":"Legault Pierre","owner_display_name":"Legault Pierre","owner_url":"/insider/0001391045","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97860.0,"shares_display":"97,860","price_per_share":58.01,"price_display":"58.01","price_state":"stated","total_value":5676858.6,"total_display":"5,676,858.60","total_whole":"5,676,859","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-22","filed_date":"2021-12-22","scope":"insider"},{"id":4900691,"accession":"0001562180-21-007866","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-21-007866","line_url":"/filing/0001562180-21-007866#line-4","is_derivative":false,"issuer_cik":"0001391045","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001391045","owner_cik":"0001391045","owner_name":"Legault Pierre","owner_display_name":"Legault Pierre","owner_url":"/insider/0001391045","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":22.0086,"price_display":"22.01","price_state":"stated","total_value":528206.4,"total_display":"528,206.40","total_whole":"528,206","shares_owned_after":16000.0,"shares_owned_after_display":"16,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-22","filed_date":"2021-12-22","scope":"insider"},{"id":5407242,"accession":"0001209191-21-071007","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-071007","line_url":"/filing/0001209191-21-071007#line-4","is_derivative":false,"issuer_cik":"0001391045","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001391045","owner_cik":"0001391045","owner_name":"Legault Pierre","owner_display_name":"Legault Pierre","owner_url":"/insider/0001391045","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44537.0,"shares_display":"44,537","price_per_share":57.11,"price_display":"57.11","price_state":"stated","total_value":2543508.07,"total_display":"2,543,508.07","total_whole":"2,543,508","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-21","filed_date":"2021-12-22","scope":"insider"},{"id":5407236,"accession":"0001209191-21-071007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-071007","line_url":"/filing/0001209191-21-071007#line-2","is_derivative":false,"issuer_cik":"0001391045","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001391045","owner_cik":"0001391045","owner_name":"Legault Pierre","owner_display_name":"Legault Pierre","owner_url":"/insider/0001391045","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7603.0,"shares_display":"7,603","price_per_share":57.02,"price_display":"57.02","price_state":"stated","total_value":433523.06,"total_display":"433,523.06","total_whole":"433,523","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-20","filed_date":"2021-12-22","scope":"insider"},{"id":4900682,"accession":"0001562180-21-007866","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-007866","line_url":"/filing/0001562180-21-007866#line-2","is_derivative":false,"issuer_cik":"0001391045","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001391045","owner_cik":"0001391045","owner_name":"Legault Pierre","owner_display_name":"Legault Pierre","owner_url":"/insider/0001391045","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":21.0125,"price_display":"21.01","price_state":"stated","total_value":420250.0,"total_display":"420,250.00","total_whole":"420,250","shares_owned_after":16000.0,"shares_owned_after_display":"16,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-20","filed_date":"2021-12-22","scope":"insider"},{"id":5193355,"accession":"0001209191-21-026247","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-026247","line_url":"/filing/0001209191-21-026247","is_derivative":false,"issuer_cik":"0001391045","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001391045","owner_cik":"0001391045","owner_name":"Legault Pierre","owner_display_name":"Legault Pierre","owner_url":"/insider/0001391045","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24838.0,"shares_display":"24,838","price_per_share":31.70898099685965,"price_display":"31.71","price_state":"stated","total_value":787587.67,"total_display":"787,587.67","total_whole":"787,588","shares_owned_after":12338.0,"shares_owned_after_display":"12,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-08","filed_date":"2021-04-09","scope":"insider","n_lines":3},{"id":5395389,"accession":"0001209191-21-025990","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-025990","line_url":"/filing/0001209191-21-025990#line-2","is_derivative":false,"issuer_cik":"0001391045","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001391045","owner_cik":"0001391045","owner_name":"Legault Pierre","owner_display_name":"Legault Pierre","owner_url":"/insider/0001391045","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":162.0,"shares_display":"162","price_per_share":31.07,"price_display":"31.07","price_state":"stated","total_value":5033.34,"total_display":"5,033.34","total_whole":"5,033","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-07","scope":"insider"},{"id":4529386,"accession":"0001209191-21-024639","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-024639","line_url":"/filing/0001209191-21-024639#line-2","is_derivative":false,"issuer_cik":"0001391045","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001391045","owner_cik":"0001391045","owner_name":"Legault Pierre","owner_display_name":"Legault Pierre","owner_url":"/insider/0001391045","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-31","filed_date":"2021-04-02","scope":"insider"},{"id":5094192,"accession":"0001209191-21-022103","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-022103","line_url":"/filing/0001209191-21-022103#line-2","is_derivative":false,"issuer_cik":"0001391045","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001391045","owner_cik":"0001391045","owner_name":"Legault Pierre","owner_display_name":"Legault Pierre","owner_url":"/insider/0001391045","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7784.0,"shares_display":"7,784","price_per_share":29.0,"price_display":"29.00","price_state":"stated","total_value":225736.0,"total_display":"225,736.00","total_whole":"225,736","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-17","filed_date":"2021-03-19","scope":"insider"},{"id":4528777,"accession":"0001209191-21-021154","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-021154","line_url":"/filing/0001209191-21-021154#line-2","is_derivative":false,"issuer_cik":"0001391045","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001391045","owner_cik":"0001391045","owner_name":"Legault Pierre","owner_display_name":"Legault Pierre","owner_url":"/insider/0001391045","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2216.0,"shares_display":"2,216","price_per_share":29.0,"price_display":"29.00","price_state":"stated","total_value":64264.0,"total_display":"64,264.00","total_whole":"64,264","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-12","filed_date":"2021-03-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001395937","name":"Syndax Pharmaceuticals Inc","url":"/issuer/0001395937","role":"Director","n_filings":3,"first_seen":"2021-12-22","last_seen":"2023-01-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001761612","name":"BICYCLE THERAPEUTICS plc","url":"/issuer/0001761612","role":"Director","n_filings":6,"first_seen":"2021-03-16","last_seen":"2021-12-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001391045","retrieved_at":"2026-08-24T03:01:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}